Cancer Stem Cells -

Cancer Stem Cells

William L. Farrar (Herausgeber)

Buch | Hardcover
182 Seiten
2009
Cambridge University Press (Verlag)
978-0-521-89628-3 (ISBN)
114,70 inkl. MwSt
The cancer stem cell hypothesis has challenged the foundational notions of cancer, and the therapeutic implications have been profound. This book discusses the emerging field of research, with contributions from leading experts on basic biology, genetic pathways, and potential for therapeutic targeting of cancer stem cells.
A remarkable paradigm shift has occurred in recent years regarding the biological origins of cancer. The cancer stem cell hypothesis challenged the foundational notions of cancer, and the therapeutic implications have been profound. Compelling evidence indicates that errors in the development of a small subset of adult stem cells can lead to cancer. Only this small sub-population of cells has the inherent ability to form tumours and metastasize. This book discusses the emerging field of cancer stem cell research, with contributions from leading experts on the basic biology, genetic pathways, and potentials for therapeutic targeting of cancer stem cells. It also covers clinical challenges for these new discoveries, namely, that cancer stem cells might be resistant to conventional chemotherapeutic and radiological treatments and may be at the biological core of relapse and therapeutic resistance. This book is an essential concise guide to the latest discoveries and therapies in cancer research.

William L. Farrar, PhD, is Head of the Cancer Stem Cell Section at the Laboratory of Cancer Prevention, National Cancer Institute, Frederick, Maryland.

Preface William L. Farrar; 1. Purification and characterization of cancer stem cells Elaine M. Hurt and William L. Farrar; 2. Prostate cancer stem cells Collene R. Jeter and Dean G. Tang; 3. Melanoma cancer stem cells Alexander Roesch and Meenhard Herlyn; 4. Mammospheres and breast carcinoma Massimiliano Bonafe; 5. Preventative and therapeutic strategies for cancer stem cells Stewart Sell and Gennadi Glinsky; 6. Targeting AML stem cells Monica L. Guzman, Gerrit J. Schuurhuis, and Craig T. Jordan; 7. Plasticity of multi-potent tumor cells and ES cells Lynne-Marie Postovit, Naira V. Margaryan, Elisabeth A. Seftor, Luigi Strizzi, Richard E. B. Seftor, and Mary J. C. Hendrix; 8. Hedgehog and GLI signaling in cancer Fritz Aberger; 9. Targeting notch signaling pathway in cancer stem cells Joon T. Park, Ie-Ming Shih, and Tian-Li Wang; 10. WNT-Beta catenin signaling in cancer Stephen Byers, Michael Pishvaian, Lopa Mishra, and Robert Glazer.

Erscheint lt. Verlag 24.8.2009
Zusatzinfo 9 Tables, unspecified; 16 Plates, color; 7 Halftones, unspecified; 5 Line drawings, unspecified
Verlagsort Cambridge
Sprache englisch
Maße 182 x 260 mm
Gewicht 640 g
Themenwelt Medizinische Fachgebiete Innere Medizin Hämatologie
Medizin / Pharmazie Medizinische Fachgebiete Onkologie
Naturwissenschaften Biologie Genetik / Molekularbiologie
Naturwissenschaften Biologie Zellbiologie
ISBN-10 0-521-89628-2 / 0521896282
ISBN-13 978-0-521-89628-3 / 9780521896283
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
Hämatologie und Internistische Onkologie

von Dietmar P. Berger; Monika Engelhardt; Justus Duyster

Buch | Softcover (2023)
ecomed-Storck GmbH (Verlag)
129,99